Prenatal Genetic Diagnosis of a Sex Chromosome Aneuploidy: Parent Experiences

Prenatal Genetic Diagnosis of a Sex Chromosome Aneuploidy: Parent Experiences
Sex chromosome aneuploidies (SCAs) happen in 1 in each 400 births. SCAs are extremely variable and have unsure prognoses, complicating the supply of prenatal cell-free DNA (cfDNA) outcomes or analysis following amniocentesis or chorionic villus sampling. Using a mixed-methods strategy, we explored the experiences of mother and father receiving a prenatal analysis of a fetus with SCA. Responses to open-ended questions had been qualitatively analyzed. Of the 323 mother and father who accomplished the survey, 122 obtained a prenatal analysis and answered no less than one open-ended query.
Most mother and father didn’t recall being knowledgeable that cfDNA screening or amniocentesis might reveal the presence of a SCA previous to testing and described feeling unprepared for a optimistic end result. Variation was discovered between mother and father who had been delivered a analysis by a genetic skilled versus different scientific specialties. Many mother and father expressed that the analysis was delivered in a means that emphasised the unfavorable attributes of the SCA and that they had been supplied restricted help supplies.
Parents who obtained a prenatal analysis of a SCA expressed a need for extra supportive supply of prenatal analysis that focuses on parental training and nuanced dialogue of potential phenotypes. Genetic counselors needs to be conscious of the vary of parental experiences when receiving a SCA analysis from non-genetic suppliers. Prenatal SCA diagnoses are predicted to extend as prenatal cfDNA screening turns into extra broadly used. Collaborations for higher supplier training and complete supplies on SCAs are important to facilitate the supply of SCA diagnoses and enhance guardian understanding and help.

Inference of inhabitants genetic parameters from an irregular time collection of seasonal influenza virus sequences

Basic abstract statistics that quantify the inhabitants genetic construction of influenza virus are essential for understanding and inferring the evolutionary and epidemiological processes. However, the sampling dates of international virus sequences within the final a number of a long time are scattered nonuniformly all through the calendar. Such temporal construction of samples and the small efficient measurement of viral inhabitants hampers the use of typical strategies to calculate abstract statistics.
Here, we outline statistics that overcome this downside by correcting for the sampling-time distinction in quantifying a pairwise sequence distinction. A easy linear regression technique collectively estimates the mutation price and the extent of sequence polymorphism, thus offering an estimate of the efficient inhabitants measurement. It additionally results in the definition of Wright’s FST for arbitrary time-series information. Furthermore, as a substitute for Tajima’s D statistic or the site-frequency spectrum, a mismatch distribution corrected for sampling-time variations could be obtained and in contrast between precise and simulated information.
Application of these strategies to seasonal influenza A/H3N2 viruses sampled between 1980 and 2017 and sequences simulated underneath the mannequin of recurrent optimistic choice with metapopulation dynamics allowed us to estimate the synonymous mutation price and discover parameter values for choice and demographic construction that match the remark. We discovered that the mutation charges of HA and PB1 segments earlier than 2007 had been notably excessive and that together with recurrent optimistic choice in our mannequin was important for the genealogical construction of the HA section. Methods developed right here could be typically utilized to inhabitants genetic inferences utilizing serially sampled genetic information.

Atypical Genetic Basis of Pyrazinamide Resistance in Mono-resistant Mycobacterium tuberculosis

Pyrazinamide (PZA) is a broadly used antitubercular chemotherapeutic. Typically, PZA resistance (PZA-R) emerges in M. tuberculosis strains with current resistance to isoniazid and rifampicin (MDR) and is conferred by loss-of-function pncA mutations that inhibit conversion to its energetic kind, Pyrazinoic acid (POA). PZA-R departing from this canonical situation is poorly understood. Here, we genotype pncA and purported various PZA-R genes (panD, rpsA, and clpC1) with long-read sequencing of nineteen phenotypically PZA mono-resistant isolates collected in Sweden and evaluate their phylogenetic and genomic traits to a giant set of MDR PZA-R (MDRPZA-R) isolates. We report the primary affiliation of ClpC1 mutations with PZA-R in scientific isolates, within the ClpC1 promoter (clpC1p -138) and N-terminal (ClpC1Val63Ala).
Mutations have emerged in each these areas underneath POA choice in vitro and ClpC1N-terminal has been implicated additional, by its POA-dependent efficacy in PanD proteolysis. ClpC1Val63Ala mutants spanned 4 Indo-oceanic sublineages. Indo-oceanic isolates invariably harbored ClpC1Val63Ala and had been starkly overrepresented (OR=22.2, p <0.00001) amongst PZA mono-resistant isolates (11/19) in comparison with MDRPZA-R isolates (5/80). The genetic foundation of Indo-oceanic isolates’ overrepresentation in PZA mono-resistant TB stays undetermined, however substantial circumstantial proof suggests ClpC1Val63Ala confers low-level PZA resistance. Our findings spotlight ClpC1 as doubtlessly clinically related for PZA-R and reinforce the significance of genetic background within the trajectory of resistance growth.

Exploring mother and father’ perceptions of the worth of pediatric genetic counseling affected person letters: A qualitative research presenting classes realized

Genetic counseling affected person letters are a helpful complement to genetic counseling follow. As the demand for genetic companies will increase, enhancing effectivity in each day duties resembling letter writing might enhance genetic counselor workflow. Additionally, understanding the worth recipients place on the content material of these letters previous to creating efficiencies is important towards making certain that the utility of these letters will not be misplaced. To higher perceive mother and father’ perceptions of the letter’s worth within the pediatric genetic counseling setting, we employed a qualitative design involving 13 mother and father of youngsters who obtained a affected person letter following their analysis.
Prenatal Genetic Diagnosis of a Sex Chromosome Aneuploidy: Parent Experiences
Parents participated in a semi-structured focus group, interview, or cellphone interview, and the info had been analyzed utilizing thematic evaluation. In addition to gathering perceptions of their kid’s letter, we sought to study preferences for letter size, formatting, and stage of element by asking for verbal and written suggestions on three totally different letter codecs created for a fictional affected person. We used self-determination concept (SDT) framework to create the pattern letters, which states that a person’s expertise of autonomy, competence, and relatedness can influence their capacity to interact in actions.

Recombinant Echis ocellatus C-type lectin 2

MBS1323829-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis ocellatus C-type lectin 2

MBS1323829-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis ocellatus C-type lectin 2

MBS1323829-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis ocellatus C-type lectin 2

MBS1323829-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis ocellatus C-type lectin 27

MBS1475643-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis ocellatus C-type lectin 27

MBS1475643-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis ocellatus C-type lectin 27

MBS1475643-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis ocellatus C-type lectin 27

MBS1475643-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis ocellatus C-type lectin 27

MBS1475643-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis ocellatus C-type lectin 1

MBS1373490-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis ocellatus C-type lectin 1

MBS1373490-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis ocellatus C-type lectin 1

MBS1373490-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis ocellatus C-type lectin 1

MBS1373490-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis ocellatus C-type lectin 1

MBS1373490-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis pyramidum leakeyi C-type lectin 7

MBS1478837-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis pyramidum leakeyi C-type lectin 7

MBS1478837-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis pyramidum leakeyi C-type lectin 7

MBS1478837-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis pyramidum leakeyi C-type lectin 7

MBS1478837-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis pyramidum leakeyi C-type lectin 7

MBS1478837-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis pyramidum leakeyi C-type lectin 1

MBS1357827-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis pyramidum leakeyi C-type lectin 1

MBS1357827-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis pyramidum leakeyi C-type lectin 1

MBS1357827-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis pyramidum leakeyi C-type lectin 1

MBS1357827-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis pyramidum leakeyi C-type lectin 1

MBS1357827-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis pyramidum leakeyi C-type lectin 4

MBS1375934-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis pyramidum leakeyi C-type lectin 4

MBS1375934-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis pyramidum leakeyi C-type lectin 4

MBS1375934-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis pyramidum leakeyi C-type lectin 4

MBS1375934-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis pyramidum leakeyi C-type lectin 4

MBS1375934-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis pyramidum leakeyi C-type lectin 5

MBS1325024-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis pyramidum leakeyi C-type lectin 5

MBS1325024-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis pyramidum leakeyi C-type lectin 5

MBS1325024-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis pyramidum leakeyi C-type lectin 5

MBS1325024-01mgEColi 0.1mg(E-Coli)
EUR 725

Recombinant Echis pyramidum leakeyi C-type lectin 5

MBS1325024-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis carinatus sochureki C-type lectin 1

MBS1320689-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis carinatus sochureki C-type lectin 1

MBS1320689-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis carinatus sochureki C-type lectin 1

MBS1320689-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis carinatus sochureki C-type lectin 1

MBS1320689-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis carinatus sochureki C-type lectin 1

MBS1320689-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis carinatus sochureki C-type lectin 9

MBS1459320-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis carinatus sochureki C-type lectin 9

MBS1459320-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis carinatus sochureki C-type lectin 9

MBS1459320-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis carinatus sochureki C-type lectin 9

MBS1459320-01mgEColi 0.1mg(E-Coli)
EUR 725

Recombinant Echis carinatus sochureki C-type lectin 9

MBS1459320-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis carinatus sochureki C-type lectin 3

MBS1381815-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis carinatus sochureki C-type lectin 3

MBS1381815-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis carinatus sochureki C-type lectin 3

MBS1381815-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis carinatus sochureki C-type lectin 3

MBS1381815-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis carinatus sochureki C-type lectin 3

MBS1381815-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis carinatus sochureki C-type lectin 8

MBS1358562-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis carinatus sochureki C-type lectin 8

MBS1358562-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis carinatus sochureki C-type lectin 8

MBS1358562-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis carinatus sochureki C-type lectin 8

MBS1358562-01mgEColi 0.1mg(E-Coli)
EUR 730

Recombinant Echis carinatus sochureki C-type lectin 8

MBS1358562-01mgYeast 0.1mg(Yeast)
EUR 935

Echinococcus IgG (Echinococcosis, Hydatidosis)

GWB-5571AC 1x96 Assays Ask for price

Recombinant Echis carinatus Echicetin subunit beta

MBS1400202-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis carinatus Echicetin subunit beta

MBS1400202-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis carinatus Echicetin subunit beta

MBS1400202-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis carinatus Echicetin subunit beta

MBS1400202-01mgEColi 0.1mg(E-Coli)
EUR 725

Recombinant Echis carinatus Echicetin subunit beta

MBS1400202-01mgYeast 0.1mg(Yeast)
EUR 935

Recombinant Echis carinatus Echicetin subunit alpha

MBS1453456-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1055

Recombinant Echis carinatus Echicetin subunit alpha

MBS1453456-002mgEColi 0.02mg(E-Coli)
EUR 635

Recombinant Echis carinatus Echicetin subunit alpha

MBS1453456-002mgYeast 0.02mg(Yeast)
EUR 805

Recombinant Echis carinatus Echicetin subunit alpha

MBS1453456-01mgEColi 0.1mg(E-Coli)
EUR 740

Recombinant Echis carinatus Echicetin subunit alpha

MBS1453456-01mgYeast 0.1mg(Yeast)
EUR 945

Porcine echinococcus antibody IgG(echinococcus- IgG) ELISA Kit

SL0244Po - Ask for price

Canine echinococcur antibody IgG ( echinococcur-IgG) ELISA Kit

SL0026Ca -
EUR 528

Canine echinococcur antibody IgG ( echinococcur-IgG) ELISA Kit

NSL2104Ca each Ask for price

Recombinant Echis carinatus sochureki Echicetin subunit alpha

MBS1019449-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1055

Recombinant Echis carinatus sochureki Echicetin subunit alpha

MBS1019449-002mgEColi 0.02mg(E-Coli)
EUR 635

Recombinant Echis carinatus sochureki Echicetin subunit alpha

MBS1019449-002mgYeast 0.02mg(Yeast)
EUR 810

Recombinant Echis carinatus sochureki Echicetin subunit alpha

MBS1019449-01mgEColi 0.1mg(E-Coli)
EUR 740

Recombinant Echis carinatus sochureki Echicetin subunit alpha

MBS1019449-01mgYeast 0.1mg(Yeast)
EUR 945

Recombinant Echis carinatus sochureki Echicetin subunit beta

MBS1086463-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Echis carinatus sochureki Echicetin subunit beta

MBS1086463-002mgEColi 0.02mg(E-Coli)
EUR 625

Recombinant Echis carinatus sochureki Echicetin subunit beta

MBS1086463-002mgYeast 0.02mg(Yeast)
EUR 800

Recombinant Echis carinatus sochureki Echicetin subunit beta

MBS1086463-01mgEColi 0.1mg(E-Coli)
EUR 725

Recombinant Echis carinatus sochureki Echicetin subunit beta

MBS1086463-01mgYeast 0.1mg(Yeast)
EUR 935

Echinatin

461252 50.0mg
EUR 450

Echinatin

HY-N0269 10mg
EUR 338.4

Echinatin

N2427-20 20 mg
EUR 160
Description: Extracted from Leguminosae Glycyrrhiza uralensis Fisch. root and rhizome;Store the product in sealed, cool and dry condition

Echioidin

T131487-10mg 10mg Ask for price
Description: Echioidin

Echioidin

T131487-1g 1g Ask for price
Description: Echioidin

Echioidin

T131487-1mg 1mg Ask for price
Description: Echioidin

Echioidin

T131487-50mg 50mg Ask for price
Description: Echioidin

Echioidin

T131487-5mg 5mg Ask for price
Description: Echioidin

Echiumine

T124507-10mg 10mg Ask for price
Description: Echiumine

Echiumine

T124507-1g 1g Ask for price
Description: Echiumine

Echiumine

T124507-1mg 1mg Ask for price
Description: Echiumine

Echiumine

T124507-50mg 50mg Ask for price
Description: Echiumine

Echiumine

T124507-5mg 5mg Ask for price
Description: Echiumine

Echinatin

TB0554 20mg
EUR 478.8

Echinulin

TN3916-10mg 10mg Ask for price
Description: Echinulin

Echinulin

TN3916-1g 1g Ask for price
Description: Echinulin

Echinulin

TN3916-1mg 1mg Ask for price
Description: Echinulin

Echinulin

TN3916-50mg 50mg Ask for price
Description: Echinulin

Echinulin

TN3916-5mg 5mg Ask for price
Description: Echinulin

Echinatin

T3926-10mg 10mg Ask for price
Description: Echinatin

Echinatin

T3926-1g 1g Ask for price
Description: Echinatin

Echinatin

T3926-1mg 1mg Ask for price
Description: Echinatin

Echinatin

T3926-50mg 50mg Ask for price
Description: Echinatin

Echinatin

T3926-5mg 5mg Ask for price
Description: Echinatin

Echioidin

MBS5796423-INQUIRE INQUIRE Ask for price

Echiumine

MBS5790011-INQUIRE INQUIRE Ask for price

Echinatin

MBS384055-10mg 10mg
EUR 285

Echinatin

MBS384055-25mg 25mg
EUR 360

Echinatin

MBS384055-5mg 5mg
EUR 210

Echinatin

MBS384055-5x25mg 5x25mg
EUR 1600

Echinatin

MBS3608440-10mg 10mg
EUR 310

Echinatin

MBS3608440-25mg 25mg
EUR 410

Echinatin

MBS3608440-5mg 5mg
EUR 250

Echinatin

MBS3608440-5x25mg 5x25mg
EUR 1520

Echinatin

MBS5750279-10mg 10mg
EUR 245

Echinatin

MBS5750279-1mg 1mg
EUR 145

Echinatin

MBS5750279-25mg 25mg
EUR 345

Echinatin

MBS5750279-2mg 2mg
EUR 165

Echinatin

MBS5750279-5mg 5mg
EUR 190

Echinulin

MBS5762290-1mg 1mg
EUR 300

Echinulin

MBS5762290-5x1mg 5x1mg
EUR 1190

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-beta

MBS1415239-002mgBaculovirus 0.02mg(Baculovirus)
EUR 975

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-beta

MBS1415239-002mgEColi 0.02mg(E-Coli)
EUR 535

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-beta

MBS1415239-002mgYeast 0.02mg(Yeast)
EUR 730

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-beta

MBS1415239-01mgEColi 0.1mg(E-Coli)
EUR 635

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-beta

MBS1415239-01mgYeast 0.1mg(Yeast)
EUR 850

Echistatin

4030571.01 0.1 mg
EUR 347.13

Echistatin

4030571.05 0.5 mg
EUR 1385.27

Echinuline

463381 1.0mg
EUR 380

Echimidine

564495 10.0mg
EUR 905

Echistatin

H-9010.0100 0.1mg
EUR 572.4
Description: Sum Formula: C217H341N71O74S9; CAS# [154303-05-6]

Echistatin

H-9010.0500 0.5mg
EUR 2184
Description: Sum Formula: C217H341N71O74S9; CAS# [154303-05-6]

Echinoside B

T25359-10mg 10mg Ask for price
Description: Echinoside B

Echinoside B

T25359-1g 1g Ask for price
Description: Echinoside B

Echinoside B

T25359-1mg 1mg Ask for price
Description: Echinoside B

Echinoside B

T25359-50mg 50mg Ask for price
Description: Echinoside B

Echinoside B

T25359-5mg 5mg Ask for price
Description: Echinoside B

Echistatin

TP2098-10mg 10mg Ask for price
Description: Echistatin

Echistatin

TP2098-1g 1g Ask for price
Description: Echistatin

Echistatin

TP2098-1mg 1mg Ask for price
Description: Echistatin

Echistatin

TP2098-50mg 50mg Ask for price
Description: Echistatin

Echistatin

TP2098-5mg 5mg Ask for price
Description: Echistatin

Echimidine

TBZ2401 unit Ask for price

Echimidine

TN3913-10mg 10mg Ask for price
Description: Echimidine

Echimidine

TN3913-1g 1g Ask for price
Description: Echimidine

Echimidine

TN3913-1mg 1mg Ask for price
Description: Echimidine

Echimidine

TN3913-50mg 50mg Ask for price
Description: Echimidine

Echimidine

TN3913-5mg 5mg Ask for price
Description: Echimidine

Echinatine

TN3914-10mg 10mg Ask for price
Description: Echinatine

Echinatine

TN3914-1g 1g Ask for price
Description: Echinatine

Echinatine

TN3914-1mg 1mg Ask for price
Description: Echinatine

Echinatine

TN3914-50mg 50mg Ask for price
Description: Echinatine

Echinatine

TN3914-5mg 5mg Ask for price
Description: Echinatine

Echitamine

TN3917-10mg 10mg Ask for price
Description: Echitamine

Echitamine

TN3917-1g 1g Ask for price
Description: Echitamine

Echitamine

TN3917-1mg 1mg Ask for price
Description: Echitamine

Echitamine

TN3917-50mg 50mg Ask for price
Description: Echitamine

Echitamine

TN3917-5mg 5mg Ask for price
Description: Echitamine

Echinoside B

MBS5775090-5mg 5(mg
EUR 915

Echinoside B

MBS5775090-5x5mg 5x5(mg
EUR 3970

Echinatine

MBS5787101-INQUIRE INQUIRE Ask for price

Echistatin (1-49)

MBS659742-1mg 1mg
EUR 1425

Echistatin (1-49)

MBS659742-5x1mg 5x1mg
EUR 6250

Echistatin

MBS405744-1mg 1mg
EUR 1350

Echistatin

MBS405744-5mg 5mg
EUR 5145

Echistatin

MBS405744-5x1mg 5x1mg
EUR 6005

Echimidine

MBS5762289-1mg 1mg
EUR 300

Echimidine

MBS5762289-5x1mg 5x1mg
EUR 1200

Echitamine

MBS5762291-1mg 1mg
EUR 315

Echitamine

MBS5762291-5x1mg 5x1mg
EUR 1260

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-gamma

MBS1311734-002mgBaculovirus 0.02mg(Baculovirus)
EUR 975

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-gamma

MBS1311734-002mgEColi 0.02mg(E-Coli)
EUR 535

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-gamma

MBS1311734-002mgYeast 0.02mg(Yeast)
EUR 725

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-gamma

MBS1311734-01mgEColi 0.1mg(E-Coli)
EUR 635

Recombinant Echis pyramidum leakeyi Disintegrin echistatin-gamma

MBS1311734-01mgYeast 0.1mg(Yeast)
EUR 850

Echinomycin

329824 1.0mg
EUR 190

Echinomycin

T15197-10mg 10mg Ask for price
Description: Echinomycin

Echinomycin

T15197-1g 1g Ask for price
Description: Echinomycin

Echinomycin

T15197-1mg 1mg Ask for price
Description: Echinomycin

Echinomycin

T15197-50mg 50mg Ask for price
Description: Echinomycin

Echinomycin

T15197-5mg 5mg Ask for price
Description: Echinomycin

Echioidinin

T131518-10mg 10mg Ask for price
Description: Echioidinin

Echioidinin

T131518-1g 1g Ask for price
Description: Echioidinin

Echioidinin

T131518-1mg 1mg Ask for price
Description: Echioidinin

Echioidinin

T131518-50mg 50mg Ask for price
Description: Echioidinin

Echioidinin

T131518-5mg 5mg Ask for price
Description: Echioidinin

Echinomycin

abx282655-100g 100 µg Ask for price

Echinomycin

abx282655-20g 20 µg
EUR 168.75
This consists of caring for a baby with particular medical wants. While the findings from this work strengthened the significance of written communication for sufferers as seen in earlier analysis, this work uncovered three main themes in regards to the letter’s worth: (a) parts resembling readability and content material influence guardian emotions of autonomy and enhance competence shifting ahead with their kid’s care; (b) mother and father worth written acknowledgment of the emotional influence of the analysis; and (c) mother and father use the letter as a instrument to speak their kid’s analysis with others. These outcomes can be utilized for creating understandable affected person letters that help autonomy, competence, and relatedness.

The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms

The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms
Nonalcoholic fatty liver illness (NAFLD) is characterised by hepatic lipid accumulation. SAMM50 encodes Sam50, a mitochondrial outer membrane protein concerned in the elimination of reactive oxygen species, mitochondrial morphology, and regulation of mitophagy. Certain single nucleotide polymorphisms (SNPs) of SAMM50 have been reported to be correlated with NAFLD.
However, the contribution of SAMM50 polymorphisms to the prevalence and severity of fatty liver in the Chinese Han cohort has not often been reported. Here, we investigated the affiliation between SAMM50 polymorphisms (rs738491 and rs2073082) and NAFLD in a Chinese Han cohort, in addition to the mechanistic foundation of this affiliation. Clinical data and blood samples had been collected from 380 NAFLD instances and 380 regular topics for the detection of genotypes and biochemical parameters. Carriers of the rs738491 T-allele or rs2073082 G-allele of SAMM50 exhibit elevated susceptibility to NAFLD (OR=1.39; 95% CI=1.14-1.71, P=0.001; OR=1.31; 95% CI=1.05-1.62, P=0.016, respectively) and are correlated with elevated serum TG, ALT, and AST ranges.
The presence of the T allele (TT+CT) of rs738491 (P<0.01) or G allele (AG+GG) of rs2073082 (P=0.03) is correlated with the severity of fatty liver in the NAFLD cohort. In vitro research indicated that SAMM50 gene polymorphisms lower its expression and SAMM50 deficiency outcomes in elevated lipid accumulation due to a lower in fatty acid oxidation. Overexpression of SAMM50 enhances fatty acid oxidation and mitigates intracellular lipid accumulation. Our outcomes affirm the affiliation between the SAMM50 rs738491 and rs2073082 polymorphisms and the danger of fatty liver in a Chinese cohort. The underlying mechanism could also be associated to decreased fatty acid oxidation attributable to SAMM50 deficiency.

Cross-species transcriptomics uncovers genes underlying genetic lodging of developmental plasticity in spadefoot toads

That hardcoded genomes can manifest as plastic phenotypes responding to environmental perturbations is a captivating function of residing organisms. How such developmental plasticity is regulated on the molecular stage is starting to be uncovered aided by the event of -omic strategies. Here, we evaluate the transcriptome-wide responses of two species of spadefoot toads with differing capability for developmental acceleration of their larvae in the face of a shared environmental danger: pond drying.
By evaluating gene expression profiles over time and performing cross-species community analyses, we recognized orthologues and purposeful gene pathways whose environmental sensitivity in expression have diverged between species. Genes associated to lipid, ldl cholesterol and steroid biosynthesis and metabolism make up most of a module of genes environmentally responsive in one species, however canalized in the opposite. The evolutionary adjustments in the regulation of the genes recognized by means of these analyses might have been key in the genetic lodging of developmental plasticity in this technique.

Development of Host-Orthogonal Genetic Systems for Synthetic Biology

The building of a host-orthogonal genetic system can’t solely decrease the affect of host-specific nuances on fine-tuning of gene expression, but in addition broaden mobile features equivalent to in vivo steady evolution of genes based mostly on an error-prone DNA polymerase. It represents an rising highly effective strategy for making biology simpler to engineer.
In this evaluation, the latest advances are described on the design of genetic methods that may be stably inherited in the host cells and are answerable for necessary organic processes together with DNA replication, RNA transcription, protein translation, and gene regulation. Their functions in artificial biology are summarized and the longer term challenges and alternatives are mentioned in growing such methods.
The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms

Investigating the inhabitants construction and genetic variety of Arabian horses in Oman utilizing SNP markers

Arabian horses had been chosen for metabolic effectivity, magnificence, effectivity and endurance. Therefore, Bedouins have for hundreds of years traced their prized horses’ ancestries. With the institution of the World Arabian Horse Organization (WAHO), registration of Arabian horses grew to become centralized and international locations worldwide registered them in its database.
Most current Arabian horses in Oman right this moment had been imported after the 1970s and are predominantly flat-racing Arabians. This work geared toward revealing the genetic background and variety of Omani Arabian horses by evaluating them with Arabian horses from a various genetic background. To that finish, we genotyped 63 randomly sampled Arabian horses from Oman utilizing the Illumina Equine SNP70. For comparability, SNP genotypes of 12 Saudi Arabian horses, 27 French, 77 Egyptian, 11 Polish and 36 US Arabians had been included in the examine. We moreover included 17 Thoroughbred horses and 21 horses representing giant and small breeds as an outgroup. Our MDS evaluation and phylogenetic evaluation confirmed that the Arabian horses in Oman cluster primarily with French Arabian horses, with a number of horses clustering inside the Polish/US Arabians.
The French Arabian horse cluster was the closest to the Thoroughbred horses. Amongst the Arabian horses, plink common genomic inbreeding ranges had been highest in the Egyptian Arabian (0.169) adopted by the Saudi Arabian horses (0.137) and lowest in the Omani and French Arabian horses, -0.041 and -0.079 respectively. To our data, that is the primary report on the genetic background and variety of Arabian horses in Oman. Our outcomes demonstrated a particular subpopulation construction amongst Arabian horses and this data ought to advise future decision-making on Arabian horse breeding.

A generalized sturdy allele-based genetic affiliation check

The allele-based affiliation check, evaluating allele frequency distinction between case and management teams, is regionally strongest. However, utility of the classical allelic check is restricted in apply, as a result of the tactic is delicate to the Hardy-Weinberg equilibrium (HWE) assumption, not relevant to steady traits, and never straightforward to account for covariate impact or pattern correlation.
To develop a generalized sturdy allelic check, we suggest a brand new allele-based regression mannequin with particular person allele because the response variable. We present that the rating check statistic derived from this sturdy and unifying regression framework incorporates a correction issue that explicitly adjusts for potential departure from HWE, and encompasses the classical allelic check as a particular case.
When the trait of curiosity is steady, the corresponding allelic check evaluates a weighted distinction between individual-level allele frequency estimate and pattern estimate the place the load is proportional to a person’s trait worth, and the check stays legitimate beneath Y-dependent sampling. Finally, the proposed allele-based technique can analyze a number of (steady or binary) phenotypes concurrently and multi-allelic genetic markers, whereas accounting for covariate impact, pattern correlation and inhabitants heterogeneity. To assist our analytical findings, we offer empirical proof from each simulation and utility research. This article is protected by copyright. All rights reserved.

PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice

PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice
Recently, a number of genome-wide affiliation research recognized PHACTR1 as key locus for 5 numerous vascular issues: coronary artery disease, migraine, fibromuscular dysplasia, cervical artery dissection and hypertension. Although these signify important threat components or comorbidities for ischemic stroke, PHACTR1 function in mind small vessel ischemic disease and ischemic stroke most vital survival mechanism, such because the recruitment of mind collateral arteries like posterior speaking arteries (PcomAs), stays unknown.
Therefore, we utilized exome and genome sequencing in a multi-ethnic cohort of 180 early-onset unbiased familial and apparently sporadic mind small vessel ischemic disease and CADASIL-like Caucasian patients from US, Portugal, Finland, Serbia and Turkey and in 2 C57BL/6J stroke mouse fashions (bilateral widespread carotid artery stenosis [BCCAS] and center cerebral artery occlusion [MCAO]), characterised by totally different levels of PcomAs patency. We report three very uncommon coding variants in the small vessel ischemic disease-CADASIL-like cohort (p.Glu198Gln, p.Arg204Gly, p.Val251Leu) and a stop-gain mutation (p.Gln273*) in one MCAO mouse.
These coding variants do not cluster in PHACTR1 identified pathogenic domains and are not prone to play a critical function in small vessel ischemic disease or mind collateral circulation. We additionally exclude the chance that replicate quantity variants (CNVs) or a variant enrichment in Phactr1 could also be related to PcomA recruitment in BCCAS mice or linked to numerous vascular traits (cerebral blood move pre-surgery, PcomA measurement, leptomeningeal microcollateral size and junction density throughout mind hypoperfusion) in C57BL/6J mice, respectively.
Genetic variability in PHACTR1 is not prone to be a standard susceptibility issue influencing small vessel ischemic disease in patients and PcomA recruitment in C57BL/6J mice. Nonetheless, uncommon variants in PHACTR1 RPEL domains could affect the stroke final result and are price investigating in a bigger cohort of small vessel ischemic disease patients, totally different ischemic stroke subtypes and with purposeful research.

Insight of fetal to grownup hemoglobin change: Genetic modulators and therapeutic targets

The medical heterogeneity of β-hemoglobinopathies is so variable that it prompted the researchers to determine the genetic modulators of those ailments. Though the first modulator is the kind of β-globin mutation which impacts the diploma of β-globin chain synthesis, the co-inheritance of α-thalassemia and the fetal hemoglobin (HbF) ranges additionally act as potent secondary genetic modifiers.
As elevated HbF ranges ameliorate the severity of hemoglobinopathies, in this evaluate, the genetic modulators mendacity inside and outdoors the β-globin gene cluster with their believable function in governing the HbF ranges have been summarised, which in future could act as potential therapeutic targets.
PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice

Genetic affiliation of MMP14 promoter variants and their purposeful significance in gallbladder most cancers pathogenesis

Gallbladder most cancers (GBC) is comparatively uncommon however exhibits excessive frequency in sure geographical areas and ethnic teams, which embrace Northern and Eastern states of India. Previous research in India have indicated the doable function of genetic predisposition in GBC pathogenesis. Although matrix metalloproteinase-14 (MMP14) is identified modulator of tumour microenvironment and tumorigenesis and TCGA information additionally suggests its upregulation but, its function in genetic predisposition for GBC is utterly unknown.
We explored MMP14 promoter genetic variants as threat components and their implication in expression modulation and the pathogenesis of GBC. We genotyped all single nucleotide polymorphisms of MMP14 promoter by Sanger’s sequencing in roughly 300 GBC and 300 management examine topics of Indian ethnicity and, in 26 GBC tissue samples. Protein expression of MMP14 in GBC tissue samples was checked by immunohistochemistry. In vitro luciferase reporter assay was carried out to elucidate function of promoter genetic variants on expression ranges in two totally different cell traces.
MMP14 promoter variants, rs1003349 (p worth = 0.0008) and rs1004030 (p worth = 0.0001) have been considerably related to GBC. Luciferase reporter assay confirmed excessive expression for threat alleles of each the SNPs. Genotype-phenotype correlation for rs1003349 and rs1004030, in affected person pattern, confirmed that threat allele carriers had increased expression ranges of MMP14; furthermore, the correlation sample matched with genetic affiliation fashions. Overall, this examine unravels the affiliation of MMP14 promoter SNPs with GBC which contribute to pathogenesis by rising its expression.

Compact Genetic Algorithm-based Feature Selection for Sequence-based Prediction of Dengue-Human Protein Interactions

Dengue Virus (DENV) an infection is one of many quickly spreading mosquito-borne viral infections in people. Every yr, round 50 million folks get affected by DENV an infection, ensuing in 20,000 deaths. Despite the latest experiments specializing in dengue an infection to know its performance in the human physique, a number of functionally vital DENV-human protein-protein interactions (PPIs) have remained unrecognized. This article presents a mannequin for predicting new DENV-human PPIs by combining totally different sequence-based options of human and dengue proteins just like the amino acid composition, dipeptide composition, conjoint triad, pseudo amino acid composition, and pairwise sequence similarity between dengue and human proteins.
A Learning vector quantization (LVQ)-based Compact Genetic Algorithm (CGA) mannequin is proposed for characteristic subset choice. CGA is a probabilistic approach that simulates the habits of a Genetic Algorithm (GA) with lesser reminiscence and time necessities. Prediction of DENV-human PPIs is carried out by the weighted Random Forest approach because it is discovered to carry out higher than different classifiers. We have predicted 1013 PPIs between 335 human proteins and 10 dengue proteins.

CytoSelect™ LDH Cytotoxicity Assay Kit

CBA-241 960 assays
EUR 320

CytoSelect™ Leukocyte Transmigration Assay

CBA-212 24 assays
EUR 670

CytoSelect™ MTT Cell Proliferation Assay

CBA-252 960 assays
EUR 320

CytoSelect™ 24-well Cell Migration Assay (8 μm), Colorimetric

CBA-100 12 assays
EUR 480

CytoSelect™ 24-well Cell Migration Assay (8 μm), Colorimetric

CBA-100-5 5 x 12 assays
EUR 2180

CytoSelect™ 24-well Cell Migration Assay (8 μm), Fluorometric

CBA-101 12 assays
EUR 480

CytoSelect™ 24-well Cell Migration Assay (8 μm), Fluorometric

CBA-101-5 5 x 12 assays
EUR 2180

CytoSelect™ 96-well Cell Migration Assay (8 μm), Fluorometric

CBA-106 96 assays
EUR 580

CytoSelect™ 96-well Cell Migration Assay (8 μm), Fluorometric

CBA-106-5 5 x 96 assays
EUR 2535

CytoSelect™ 24-well Wound Healing Assay

CBA-120 24 assays
EUR 595

CytoSelect™ 24-well Wound Healing Assay

CBA-120-5 5 x 24 assays
EUR 2465

CytoSelect™ BrdU Cell Proliferation ELISA Kit

CBA-251 96 assays
EUR 455

CytoSelect™ Tumor Transendothelial Migration Assay

CBA-216 24 assays
EUR 670

CytoSelect™ Cell Viability and Cytotoxicity Assay

CBA-240 96 assays
EUR 305

CytoSelect™ 96-well Cell Transformation Assay

CBA-130 96 assays
EUR 640

CytoSelect™ 96-well Cell Transformation Assay

CBA-130-5 5 x 96 assays
EUR 2695

CytoSelect™ 96-well Phagocytosis Assay (Zymosan)

CBA-224 96 assays
EUR 620

CytoSelect™ 96-well Phagocytosis Assay (Zymosan)

CBA-224-5 5 x 96 assays
EUR 2670

CytoSelect™ 24-Well Cell Co-Culture System

CBA-160 24 assays
EUR 365

CytoSelect™ 24-Well Cell Co-Culture System

CBA-160-5 5 x 24 assays
EUR 1585

CytoSelect™ 48-Well Cell Contraction Assay Kit

CBA-5021 48 assays
EUR 575

CytoSelect™ Cell Proliferation Assay Reagent (Colorimetric)

CBA-253 10 mL
EUR 320

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Colorimetric

CBA-100-FN 12 assays
EUR 505

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Fluorometric

CBA-101-FN 12 assays
EUR 505

CytoSelect™ 24-Well Wound Healing Assay, Trial Size

CBA-120-T 6 assays
EUR 295

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Colorimetric

CBA-100-COL 12 assays
EUR 505

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Fluorometric

CBA-101-COL 12 assays
EUR 505

CytoSelect™ 24-well Collagen Cell Invasion, Colorimetric

CBA-110-COL 12 assays
EUR 535

CytoSelect™ 96-well Leukocyte-endothelium Adhesion Kit

CBA-210 100 assays
EUR 495

CytoSelect™ 96-well Phagocytosis Assay (Red Blood Cell)

CBA-220 96 assays
EUR 540

CytoSelect™ 24-well Anoikis Assay (Colorimetric/Fluorometric)

CBA-080 24 assays
EUR 505

CytoSelect™ 96-well Anoikis Assay (Colorimetric/Fluorometric)

CBA-081 96 assays
EUR 525

CytoSelect™ 24-Well Cell Migration Assay (8 µm, Colorimetric Format), Trial Size

CBA-100-T 4 assays
EUR 240

CytoSelect™ 24-Well Cell Migration Assay (8 µm, Fluorometric Format), Trial Size

CBA-101-T 4 assays
EUR 240

CytoSelect™ 24-well Collagen Cell Invasion Assay, Fluorometric

CBA-111-COL 12 assays
EUR 535

CytoSelect™ 96-well Collagen Cell Invasion Assay, Fluorometric

CBA-112-COL 96 assays
EUR 705

CytoSelect™ 24-well Cell Migration Assay (5 μm), Fluorometric

CBA-102 12 assays
EUR 480

CytoSelect™ 24-well Cell Migration Assay (5 μm), Fluorometric

CBA-102-5 5 x 12 assays
EUR 2180

CytoSelect™ 24-well Cell Migration Assay (3 μm), Fluorometric

CBA-103 12 assays
EUR 480

CytoSelect™ 24-well Cell Migration Assay (3 μm), Fluorometric

CBA-103-5 5 x 12 assays
EUR 2180

CytoSelect™ 96-well Cell Migration Assay (3 μm), Fluorometric

CBA-104 96 assays
EUR 580

CytoSelect™ 96-well Cell Migration Assay (3 μm), Fluorometric

CBA-104-5 5 x 96 assays
EUR 2535

CytoSelect™ 96-well Cell Migration Assay (5 μm), Fluorometric

CBA-105 96 assays
EUR 580

CytoSelect™ 96-well Cell Migration Assay (5 μm), Fluorometric

CBA-105-5 5 x 96 assays
EUR 2535

CytoSelect™ 24-well Cell Migration Assay (12 μm), Colorimetric

CBA-107 12 assays
EUR 480

CytoSelect™ 24-well Cell Migration Assay (12 μm), Fluorometric

CBA-108 12 assays
EUR 480

CytoSelect LDH Cytotoxicity Assay Kit

MBS168668-5x960Assays 5x960Assays
EUR 2180

CytoSelect LDH Cytotoxicity Assay Kit

MBS168668-960Assays 960Assays
EUR 475

CytoSelect™ 24-well Cell Migration and Invasion Assay (8 µm), Colorimetric, Combo Kit

CBA-100-C 2 x 12 assays
EUR 915

CytoSelect™ 24-well Cell Migration and Invasion Assay (8 µm), Colorimetric, Combo Kit

CBA-100-C-5 10 x 12 assays
EUR 3950

CytoSelect™ 24-well Cell Migration and Invasion Assay (8 µm), Fluorometric, Combo Kit

CBA-101-C 2 x 12 assays
EUR 915

CytoSelect™ 96-well Cell Migration and Invasion Assay (8 µm), Fluorometric, Combo Kit

CBA-106-C 2 x 96 assays
EUR 1080

CytoSelect 24-well Cell Migration Assay (8 um), Colorimetric

MBS168121-12Assays 12Assays
EUR 660

CytoSelect 24-well Cell Migration Assay (8 um), Colorimetric

MBS168121-5x12Assays 5x12Assays
EUR 2625

CytoSelect 24-well Cell Migration Assay (8 um), Fluorometric

MBS168379-12Assays 12Assays
EUR 660

CytoSelect 24-well Cell Migration Assay (8 um), Fluorometric

MBS168379-5x12Assays 5x12Assays
EUR 2625

CytoSelect 96-well Cell Migration Assay (8 um), Fluorometric

MBS168842-5x96Assays 5x96Assays
EUR 3015

CytoSelect 96-well Cell Migration Assay (8 um), Fluorometric

MBS168842-96Assays 96Assays
EUR 775

CytoSelect IdU Competitive ELISA Kit

CBA-5100 96 assays
EUR 651.6

CytoSelect EdU Competitive ELISA Kit

CBA-5101 96 assays
EUR 651.6

CytoSelect™ 48-well Cell Adhesion Assay (Fibronectin, Colorimetric)

CBA-050 48 assays
EUR 370

CytoSelect™ 48-well Cell Adhesion Assay (Fibronectin, Fluorometric)

CBA-051 48 assays
EUR 400

CytoSelect™ 24-well Cell Invasion (Basement Membrane), Fluorometric

CBA-111 12 assays
EUR 535

CytoSelect BrdU Competitive ELISA Kit

CBA-5098 96 assays
EUR 651.6

CytoSelect Leukocyte Transmigration Assay

MBS168158-24Assays 24Assays
EUR 880

CytoSelect Leukocyte Transmigration Assay

MBS168158-5x24Assays 5x24Assays
EUR 4060

CytoSelect™ 48-well Cell Adhesion Assay (Collagen I, Colorimetric)

CBA-052 48 assays
EUR 370

CytoSelect™ 48-well Cell Adhesion Assay (Collagen I, Fluorometric)

CBA-053 48 assays
EUR 400

CytoSelect™ 48-well Cell Adhesion Assay (Collagen IV, Colorimetric)

CBA-060 48 assays
EUR 370

CytoSelect™ 48-well Cell Adhesion Assay (Collagen IV, Fluorometric)

CBA-061 48 assays
EUR 400

CytoSelect MTT Cell Proliferation Assay

MBS168154-5x960Assays 5x960Assays
EUR 2180

CytoSelect MTT Cell Proliferation Assay

MBS168154-960Assays 960Assays
EUR 475

CytoSelect™ 96-Well Phagocytosis Assay (E. coli, Colorimetric Format)

CBA-222 96 assays
EUR 595

CytoSelect 24-well Wound Healing Assay

MBS168434-24Assays 24Assays
EUR 790

CytoSelect 24-well Wound Healing Assay

MBS168434-5x24Assays 5x24Assays
EUR 2935

CytoSelect 24-well Wound Healing Assay

MBS168434-6Assays 6Assays
EUR 445

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric

CBA-135 96 assays
EUR 715

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric

CBA-135-5 5 x 96 assays
EUR 3095

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric

CBA-140 96 assays
EUR 750

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric

CBA-140-5 5 x 96 assays
EUR 3215

CytoSelect™ 24-well Cell Invasion Assay (Basement Membrane), Colorimetric

CBA-110 12 assays
EUR 535

CytoSelect™ 96-well Cell Invasion Assay (Basement Membrane), Fluorometric

CBA-112 96 assays
EUR 705

CytoSelect™ 96-Well Hematopoietic Colony Forming Cell Assay (96 assays)

CBA-320 96 assays
EUR 440

CytoSelect™ 24-Well Cell Contraction Assay Kit (Floating Matrix Model)

CBA-5020 24 assays
EUR 495

CytoSelect Tumor-endothelium Adhesion Assay

CBA-215 100 assays
EUR 692.4
Description: Leukocyte or tumor cell interactions with vascular endothelium consist of a cascade of processes including the firm attachment of cells to endothelial cell adhesion molecules. The CytoSelect Tumor Endothelium Adhesion Assay provides a robust system for the quantitative determination of interactions between tumor cells and endothelium. Adherent cells can be easily quantified on a fluorescence plate reader.

CytoSelect BrdU Cell Proliferation ELISA Kit

MBS168339-5x96Assays 5x96Assays
EUR 2900

CytoSelect BrdU Cell Proliferation ELISA Kit

MBS168339-96Assays 96Assays
EUR 630

CytoSelect Cell Viability and Cytotoxicity Assay

MBS168166-5x96Assays 5x96Assays
EUR 2090

CytoSelect Cell Viability and Cytotoxicity Assay

MBS168166-96Assays 96Assays
EUR 460

CytoSelect 96-well Cell Transformation Assay

MBS169037-5x96Assays 5x96Assays
EUR 3200

CytoSelect 96-well Cell Transformation Assay

MBS169037-96Assays 96Assays
EUR 845

CytoSelect Tumor Transendothelial Migration Assay

MBS169012-24Assays 24Assays
EUR 880

CytoSelect Tumor Transendothelial Migration Assay

MBS169012-5x24Assays 5x24Assays
EUR 4060

CytoSelect 24-Well Cell Co-Culture System

MBS168183-24Assays 24Assays
EUR 530

CytoSelect 24-Well Cell Co-Culture System

MBS168183-5x24Assays 5x24Assays
EUR 1935

CytoSelect 96-well Phagocytosis Assay (Zymosan)

MBS168370-5x96Assays 5x96Assays
EUR 3170

CytoSelect 96-well Phagocytosis Assay (Zymosan)

MBS168370-96Assays 96Assays
EUR 820

CytoSelect 96-well Cell Invasion, Fluorometric

MBS168452-5x96Assays 5x96Assays
EUR 4250

CytoSelect 96-well Cell Invasion, Fluorometric

MBS168452-96Assays 96Assays
EUR 920

CytoSelect 24-well Cell Invasion, Fluorometric

MBS168704-12Assays 12Assays
EUR 720

CytoSelect 24-well Cell Invasion, Fluorometric

MBS168704-5x12Assays 5x12Assays
EUR 3330

CytoSelect 384-well Cell Transformation Assay, Fluorometric

CBA-145 384 assays
EUR 1208.4
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader.

CytoSelect 384-well Cell Transformation Assay, Fluorometric

CBA-145-5 5 x 384 assays
EUR 4681.2
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader.

CytoSelect 24-well Cell Haptotaxis Assay (8 um), FN-coated, Colorimetric

MBS168739-12Assays 12Assays
EUR 685

CytoSelect 24-well Cell Haptotaxis Assay (8 um), FN-coated, Colorimetric

MBS168739-5x12Assays 5x12Assays
EUR 3150

CytoSelect 24-well Cell Haptotaxis Assay (8 um), FN-coated, Fluorometric

MBS168876-12Assays 12Assays
EUR 685

CytoSelect 24-well Cell Haptotaxis Assay (8 um), FN-coated, Fluorometric

MBS168876-5x12Assays 5x12Assays
EUR 3150

CytoSelect 48-Well Cell Contraction Assay Kit

MBS169268-48Assays 48Assays
EUR 770

CytoSelect 48-Well Cell Contraction Assay Kit

MBS169268-5x48Assays 5x48Assays
EUR 3545

CytoSelect 24-well Cell Haptotaxis Assay (8 um), COL-coated, Colorimetric

MBS168697-12Assays 12Assays
EUR 685

CytoSelect 24-well Cell Haptotaxis Assay (8 um), COL-coated, Colorimetric

MBS168697-5x12Assays 5x12Assays
EUR 3150

CytoSelect 24-well Cell Haptotaxis Assay (8 um), COL-coated, Fluorometric

MBS169224-12Assays 12Assays
EUR 685

CytoSelect 24-well Cell Haptotaxis Assay (8 um), COL-coated, Fluorometric

MBS169224-5x12Assays 5x12Assays
EUR 3150

CytoSelect™ 96-Well Hematopoietic Colony Forming Cell Assay (5 x 96 assays)

CBA-320-5 5 x 96 assays
EUR 1885

CytoSelect™ 24-Well Cell Migration Assay (3 µm, Fluorometric Format), Trial Size

CBA-103-T 4 assays
EUR 240

CytoSelect™ 96-well In Vitro Tumor Sensitivity Assay (Soft Agar Colony Formation)

CBA-150 96 assays
EUR 670

CytoSelect™ 96-well In Vitro Tumor Sensitivity Assay (Soft Agar Colony Formation)

CBA-150-5 5 x 96 assays
EUR 2935

CytoSelect Cell Proliferation Assay Reagent (Fluorometric)

CBA-250 10 mL
EUR 490.8
Description: Cell Biolabs? CytoSelect Cell Proliferation Assay Reagent (Fluorometric) provides a fluorometric format for measuring and monitoring cell proliferation. Cells can be plated and then treated with compounds or agents that affect proliferation.  Cells are then incubated with the proliferation reagent.  Upon entering metabolically active live cells, the non-fluorescent proliferation reagent is converted into a bright red fluorescent form. An increase in cell proliferation is accompanied by increased fluorescent signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions.  The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues.  This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. The kit contains sufficient reagents for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates.

CytoSelect Cell Proliferation Assay Reagent (Colorimetric)

MBS169040-10mL 10mL
EUR 455

CytoSelect Cell Proliferation Assay Reagent (Colorimetric)

MBS169040-5x10mL 5x10mL
EUR 1875

CytoSelect 24-well Laminin Cell Invasion, Colorimetric

CBA-110-LN 12 assays
EUR 714
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin.

CytoSelect 96-well Phagocytosis Assay (Red Blood Cell)

MBS168645-5x96Assays 5x96Assays
EUR 3355
All predicted interactions are validated by literature filtering, GO-based evaluation, and KEGG Pathway enrichment evaluation. This examine will encourage the identification of potential targets for simpler anti-dengue drug discovery.